Increasing evidence suggests that the clinical effects of transcranial magnetic stimulation are
target dependent. Within any given symptom, precise targeting of specific brain circuits may …

Transcranial magnetic stimulation (TMS) is entering increasingly widespread use in treating
depression. The most common stimulation target, in the dorsolateral prefrontal cortex …

This article updates the prior 2018 consensus statement by the National Network of
Depression Centers (NNDC) on the use of transcranial magnetic stimulation (TMS) in the …

Background A few sham-controlled studies have examined the efficacy, safety, and
tolerability of low-frequency repetitive transcranial magnetic stimulation (LF-rTMS) in …

Background Repetitive transcranial magnetic stimulation (rTMS) is effective for treatment‐
resistant depression (TRD). Optimal rTMS parameters remain unclear, especially whether …

Transcranial magnetic stimulation (TMS)-induced heart–brain coupling (HBC) has been
proposed as a technique capable of validating target engagement of the frontal-vagal …

Objective To compare the clinical efficacy of repetitive transcranial magnetic stimulation
(rTMS) under facial feature point (FFP) localization versus neuro-navigated localization for …

Background Patient expectations, including both positive (placebo) and negative (nocebo)
effects, influence treatment outcomes, yet their impact on acute repetitive transcranial …

Transcranial magnetic stimulation (TMS) is effective for major depressive disorder (MDD)
despite imprecise scalp-based targeting. Retrospective analyses suggest that targeting one …

Background Exciting left DLPFC activity with high frequency and inhibiting right DLPFC with
low frequency repetitive transcranial magnetic stimulation (rTMS) has shown antidepressant …